Vermillion (VRML) Misses Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. DOX
4. AMGN
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Vermillion (VRML) Misses Q3 EPS by 1c

Vermillion Reports Third Quarter 2016 Results

November 10, 2016 4:04 PM EST

AUSTIN, Texas, Nov. 10, 2016 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported its financial results for the third quarter ended September 30, 2016.

Valerie Palmieri, President and CEO of Vermillion, Inc., stated, "We continued to execute on our short-term and long-term goals, including reimbursement, publications, and awareness, as well as our ASPiRA pelvic mass specimen and data repository. We believe this foundation will allow us to provide solutions for women affected by a pelvic mass. Pelvic mass conditions impact 20 million women in the... More